Personalized Theratyping Trial

NCT03587961 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Symdeko

Sponsor

George Solomon